Amneal Pharmaceuticals Inc
NYSE:AMRX
Amneal Pharmaceuticals Inc
NYSE:AMRX
Price:
6.59 USD
-2.8%
Market Closed
Updated:
Jun 1, 2024
Amneal Pharmaceuticals Inc
Total Current Assets
|
Amneal Pharmaceuticals Inc
Total Current Assets Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amneal Pharmaceuticals Inc
NYSE:AMRX
|
Total Current Assets
$1.4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Current Assets
$57B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
0%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Current Assets
$28.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Current Assets
$42.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-3%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Current Assets
$31.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-3%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Current Assets
$25.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
See Also
What is Amneal Pharmaceuticals Inc's Total Current Assets?
Total Current Assets
1.4B
USD
1.4B
USD
Based on the financial report for Dec 31, 2023, Amneal Pharmaceuticals Inc's Total Current Assets amounts to 1.4B USD.
What is Amneal Pharmaceuticals Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
8%
8%
Over the last year, the Total Current Assets growth was -2%. The average annual Total Current Assets growth rates for Amneal Pharmaceuticals Inc have been -4% over the past three years , 1% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
